Evidence map›Paper›PMID 25624474›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Membranes serve as allosteric activators of phospholipase A2, enabling it to extract, bind, and hydrolyze phospholipid substrates.

Varnavas D Mouchlis, Denis Bucher, J Andrew McCammon, Edward A Dennis

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 95 citations in OpenAlex.

  1. Spider venom phospholipase D toxin structure: Interfacial binding site, mechanism, activation, and head group preference.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Specificity mechanism of Group VIA calcium-independent phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2025
    Article
  3. Article
  4. The mechanism of allosteric regulation of calcium-independent phospholipase AProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Bioactive lipids and metabolic syndrome-a symposium report.Annals of the New York Academy of Sciences · 2022
    Article
  15. Review
  16. Lipoprotein-associated phospholipase AProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Each phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Varnavas D MouchlisDepartments of Pharmacology and Chemistry and Biochemistry, and vmouchlis@ucsd.edu jmccammon@ucsd.edu edennis@ucsd.edu.
Denis BucherChemistry and Biochemistry, and.
J Andrew McCammonDepartments of Pharmacology and Chemistry and Biochemistry, and Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA 92093-0601 vmouchlis@ucsd.edu jmccammon@ucsd.edu edennis@ucsd.edu.
Edward A DennisDepartments of Pharmacology and Chemistry and Biochemistry, and vmouchlis@ucsd.edu jmccammon@ucsd.edu edennis@ucsd.edu.
Institute of Geochemistry · CNUniversity of California, San Diego · US

Funding

TrainingP41GM103712 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SEJNOWSKI, TERRENCE J · 2012 to 2021
$16.3M
ACTION OF LIPOLYTIC ENZYMESR01GM020501 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 1985 to 2020
$7.3M
DESIGN OF AMPHIPHILIC PEPTOID ASSEMBLIESF32GM020501 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BURKOTH, TIMOTHY S · 2000 to 2002
$75k
Howard Hughes Medical InstituteNIGMS NIH HHS F32 GM020501NIGMS NIH HHS GM20501NIGMS NIH HHS P41 GM103712NIGMS NIH HHS P41GM103712-S1NIGMS NIH HHS R01 GM020501
6 · The paper itself

Abstract

Defining the molecular details and consequences of the association of water-soluble proteins with membranes is fundamental to understanding protein-lipid interactions and membrane functioning. Phospholipase A2 (PLA2) enzymes, which catalyze the hydrolysis of phospholipid substrates that compose the membrane bilayers, provide the ideal system for studying protein-lipid interactions. Our study focuses on understanding the catalytic cycle of two different human PLA2s: the cytosolic Group IVA cPLA2 and calcium-independent Group VIA iPLA2. Computer-aided techniques guided by deuterium exchange mass spectrometry data, were used to create structural complexes of each enzyme with a single phospholipid substrate molecule, whereas the substrate extraction process was studied using steered molecular dynamics simulations. Molecular dynamic simulations of the enzyme-substrate-membrane systems revealed important information about the mechanisms by which these enzymes associate with the membrane and then extract and bind their phospholipid substrate. Our data support the hypothesis that the membrane acts as an allosteric ligand that binds at the allosteric site of the enzyme's interfacial surface, shifting its conformation from a closed (inactive) state in water to an open (active) state at the membrane interface.

Indexed as

Models, MolecularAllosteric RegulationCatalysisCrystallography, X-RayHumansHydrolysisMembranesMolecular Dynamics SimulationPhospholipases A2PhospholipidsProtein BindingPhospholipases A2PhospholipidsDXMSGIVA cPLA2GVIA iPLA2MD simulationsPAPC

Identifiers

PMID25624474
PMCPMC4330758
OpenAlexW2023430604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.